NGFR and melanoma: Similarly, expression of these stem cell markers has been reported in DTPs derived from various types of cancers, such as ALDH, CD133, and CD24 in NSCLS [11,35,36], SOX2, OLIG, and NFIA in glioblastoma [37,38], and JARID1B and CD271 in melanoma [14,39].